Most FGFR2 mutations are located in the Ig-III domain that has been proven to be a genetic contributor to Crouzon syndrome through the activation of one or more FGF/FGFR downstream signaling pathway(s) [17,18,19,20]. Here, FGFR2 is linked to Crouzon disease.